•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Totaligent Announces Featured Speaking Role at U.S.–Taiwan Innovation Forum, Advancing Global Biologics and Medical Tourism Collaboration
Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC
Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform
Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform
Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion
Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion
FDA's AI Push Ignites a new Biotech Arms Race and Totaligent may be quietly Positioning Itself at the Center
Totaligent Executes Definitive Agreement for Strategic Acqui-Hire of Aetherium Medical Platform
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
Totaligent Evaluates Relaunch of Previously Operated Crypto Mining Activities as Part of 2026 Strategy
Totaligent Wraps Up 2025 with Completion of Full Marketing Platform, Shares Holiday Message from CEO
Totaligent's Omni-Channel Digital Communications Platform Is an All-in-One Marketing Game Changer
24/7 Market News Shines Spotlight on Totaligent in midst of Another High-Profile Adtech Deal
Totaligent Launches New Engineering Sprint Process and Delivers Key UX & Infrastructure Improvements
Totaligent, Inc. Expands Leadership and Engineering Teams to Accelerate AI-Powered Marketing Innovation
Totaligent, Inc. Unveils Beta Website for AI-Powered Digital Marketing Platform
Totaligent, Inc. Successfully Completes PCAOB Audits for 2022 and 2023; Resumes SEC Reporting as a Voluntary Filer